arrhytmia in heart failure dr. muhammad fadil, spjp department of cardiology and vascular medicine...

Download Arrhytmia In Heart Failure Dr. Muhammad Fadil, SpJP Department of Cardiology and Vascular Medicine Medicine Faculty of Universitas Andalas/ Dr. M. Djamil

If you can't read please download the document

Upload: joanna-nichols

Post on 23-Dec-2015

219 views

Category:

Documents


5 download

TRANSCRIPT

  • Slide 1
  • Arrhytmia In Heart Failure Dr. Muhammad Fadil, SpJP Department of Cardiology and Vascular Medicine Medicine Faculty of Universitas Andalas/ Dr. M. Djamil Hospital Padang SymCARD2014 4 th
  • Slide 2
  • Introduction In heart failure patient population, cardiac arrhythmias frequently contribute to worsened symptoms, periodic decompensations, and increased mortality Arrhythmia recognition and management is an important aspect of caring for these patients Chronic heart failure predisposes to both supraventricular and ventricular arrhythmias Tedrow U and Stevenson WG. Management of Atrial and Ventricular Arrhythmias in Heart Failure. Marcel Dekker New York. 2005
  • Slide 3
  • Atrial Fibrillation (AF) SymCARD 2014 th the most common arrhytmia in heart failure AF The potential adverse effects: Loss of A-V synchrony, rapid or slow ventricular rate responses May lead to worsening of symptoms Atrial fibrillation has been associated with increased mortality and more frequent hospitalizations The potential adverse effects: Loss of A-V synchrony, rapid or slow ventricular rate responses May lead to worsening of symptoms Atrial fibrillation has been associated with increased mortality and more frequent hospitalizations Tedrow U and Stevenson WG. Management of Atrial and Ventricular Arrhythmias in Heart Failure. Marcel Dekker New York. 2005
  • Slide 4
  • 0.60.50.40.30.20.10 Solv Rx V-HeFT II SOLVD Pre CHF STAT CIBIS II EliteAVID Diamond GesicaOPTIME Consensus % Patient with Atrial Fibrilation Prevalence AF The incidence of atrial fibrillation in recent heart failure and arrhythmia trials AF is found in 6 of patients with mild heart failure and >40 of patients with advanced heart failure Thomas SA, et al. AACN Clin Iss 2001; 12(1):156163.
  • Slide 5
  • Mechanism of AF in HF January Ct, et al. Circulation;2015:129
  • Slide 6
  • ECG in Atrial Fibrillation (AF)
  • Slide 7
  • The following issues need to be considered in patients with HF and AF, especially first episode of AF or paroxysmal AF: Identification of correctable causes Identification of potential precipitating factors as this may determine whether a rhythm-control strategy is preferred to a rate control strategy Assesment for thromboembolism prophylaxis SymCARD 2014 th McMurray JJV, et al. European Heart Journal (2012) 33, 17871847 Classification and Management AF
  • Slide 8
  • Management 1.Rate Controlled SymCARD 2014 th McMurray JJV, et al. European Heart Journal (2012) 33, 17871847
  • Slide 9
  • SymCARD 2014 th McMurray JJV, et al. European Heart Journal (2012) 33, 17871847
  • Slide 10
  • SymCARD 2014 th Extreme case AV node ablation and pacing may be required CRT may be considered instead of conventional pacing McMurray JJV, et al. European Heart Journal (2012) 33, 17871847
  • Slide 11
  • SymCARD 2014 th McMurray JJV, et al. European Heart Journal (2012) 33, 17871847
  • Slide 12
  • SymCARD 2014 th McMurray JJV, et al. European Heart Journal (2012) 33, 17871847
  • Slide 13
  • In patients with Chronic HF, a rhythm-control strategy has not been demonstrated to be superior to a rate-control strategy in reducing mortality or morbidity In patient with Acute HF with haemodynamic instability emergency cardioversion SymCARD 2014 th Management 2.Rhythm Controlled
  • Slide 14
  • Amiodarone the only antiarrhythmic that should be used in patient wth systolic HF Catheter Ablation as a rhythm control strategy in HF = uncertain SymCARD 2014 th Treatment McMurray JJV, et al. European Heart Journal (2012) 33, 17871847
  • Slide 15
  • SymCARD 2014 th Most patients with systolic HF will have a risk score consistent with a firm indication for (score2) or preference for an oral anticoagulant (score=1) although bleeding risk must also be considered Management 3.Thrombo-embolism Prophylaxis McMurray JJV, et al. European Heart Journal (2012) 33, 17871847
  • Slide 16
  • SymCARD 2014 th
  • Slide 17
  • Ventricular Arrhytmias and Sudden Cardiac Death SymCARD 2014 th Sudden cardiac death : 20% to 50% of the mortality in HF Ventricular arrhythmias are a major etiology, and implantable defibrillators (ICDs) are warranted for many high-risk patients Bradyarrhythmias caused 41% of in-hospital unexpected cardiac arrests Conduction disease associated with heart failure, myocardial ischemia, antiarrhythmic and beta-adrenergic blocking drugs, and hyperkalemia are important potential etiologies Tedrow U and Stevenson WG. Management of Atrial and Ventricular Arrhythmias in Heart Failure. Marcel Dekker New York. 2005
  • Slide 18
  • Prevalence Tedrow U and Stevenson WG. Management of Atrial and Ventricular Arrhythmias in Heart Failure. Marcel Dekker New York. 2005
  • Slide 19
  • Monomorphic Ventricular Tachycardia Ischemic Mechanisme of VT Patients with Ischemic Cardiomyopathy typically have large areas of infarction. Surviving myocyte bundles present within the infarction create channels for conduction set up reentry circuits VT VT is typically monomorphic, with each QRS complex resembling the preceding and following QRS complex Tedrow U and Stevenson WG. Management of Atrial and Ventricular Arrhythmias in Heart Failure. Marcel Dekker New York. 2005
  • Slide 20
  • Monomorphic Ventricular Tachycardia non ischemic Mechanisme of VT Patients with non Ischemic Cardiomyopathy who develop sustained monomorphic VT, most have evidence of large areas of ventricular scar associated with a reentry circuit The scar may be a consequence of replacement fibrosis from the myopathic process itself or due to infarcts from embolism of left ventricular or atrial thrombus to a coronary artery. Tedrow U and Stevenson WG. Management of Atrial and Ventricular Arrhythmias in Heart Failure. Marcel Dekker New York. 2005
  • Slide 21
  • Polymorphic Ventricular Tachycardia Associated with QT interval prolongation is referred to as torsades de pointes. Any cause of QT interval prolongation can cause torsades de Pointes Mechanisme of VT Electrophysiological changes that accompany ventricular hypertrophy in chronic heart failure may increase susceptibility to torsades de pointes Torsades de pointes is often bradycardia-dependent or pause dependent, with a characteristic initiating sequence Tedrow U and Stevenson WG. Management of Atrial and Ventricular Arrhythmias in Heart Failure. Marcel Dekker New York. 2005
  • Slide 22
  • SymCARD 2014 th McMurray JJV, et al. European Heart Journal (2012) 33, 17871847
  • Slide 23
  • SymCARD 2014 th Indication for pacing Issues specific to HF 1.Before implanting a conventional pace maker in a patient with HF-REF, consider whether there is an indication for ICD, CRT-P or CRT- D 2.Because Right ventricular pacing may induced dysyncrony and worsen symptoms, CRT should be considered instead of conventional pacing in patient with HF-REF Symptomatic Bradycardia and Atrioventricular Block
  • Slide 24
  • ECG in 3 rd degree AV block
  • Slide 25
  • Take Home Messages In the heart failure patient population, cardiac arrhythmias frequently contribute to worsened symptoms, periodic decompensations, and increased mortality Atrial fibrillation and ventricular arrhythmias are common in heart failure patient
  • Slide 26
  • Take Home Messages Sudden cardiac death risk varies depending on etiology of heart failure and other clinical features Arrhythmia management in the heart failure population is complex, requiring careful integration of varied strategies including medication and procedures Treatment of arrhythmia in patient with heart failure will decrease hospitalization and mortality
  • Slide 27
  • SymCARD 2014 th Thank You